World News

Each year in the United States, more than 20 million abdomen-pelvis CT scans are performed, and the volume continues to increase.

Philips has pioneered helium-free MRI technology, installing over 2,000 of its 1.5T BlueSeal MRI systems globally and conserving more than 6 million liters of liquid helium.

Optiq AI is integrated across three new imaging platforms: Artis genio, Artis icono.explore, and Artis icono.vision/Artis pheno.vision.

Measles cases have increased globally, with an estimated 11 million infections in 2024—about 800,000 more than pre-pandemic levels in 2019.

Mjn-neuro’s wearable sensor uses artificial intelligence (AI) to analyze electrical brain signals and predict when a seizure will occur.

WT-7695, a preclinical radiopharmaceutical targeting carbonic anhydrase IX (CA9), was developed in collaboration with the University of Wisconsin-Madison, and SK now holds exclusive worldwide rights to develop, manufacture, and market the drug.

The partnership combines Philips’ next-generation MR technology with Cortechs.ai’s AI-driven quantitative neuroimaging software to transform how doctors detect, monitor, and manage neurological diseases.

The acquisition centers on Alcyone’s innovative ThecaFlex DRx drug delivery system, an experimental implantable device that represents a significant advancement in treating neurological disorders.

Construction at the MTC is currently underway and is scheduled for completion during the first half of 2027.

GEN1160 now joins GEN1107 on Genmab’s list of discontinued assets from the April 2024 ProfoundBio acquisition.